Literature DB >> 9814745

Inguinal hernia repair: a comparison between local and general anaesthesia.

P Subramaniam1, J Leslie, C Gourlay, J K Clezy.   

Abstract

BACKGROUND: A comparative analysis of outcomes of inguinal hernia repair performed under local (LA) and general anaesthesia (GA) by a single surgeon using a standardized technique of anterior transversalis repair was performed. Ninety-three cases were examined, 56 of which were cases of LA hernia repair.
METHODS: A retrospective analysis of the patient hospital record was performed with particular attention to intra-operative and post-operative analgesia requirements.
RESULTS: An overall series complication rate of 6.5% (6/93) is reported. Only one of 56 LA patients (2%) required more than 24 h of narcotic analgesic injections compared to 11% (4/37) in the GA group (P < 0.05). The mean total postoperative parenteral narcotic requirement in the LA group was 86+/-14 mg of pethidine as compared to the GA group who had a mean total requirement of 121+/-17 mg of pethidine (P > 0.08).
CONCLUSIONS: The LA infiltration technique is an effective method for inguinal hernia repair. This series demonstrates benefits in terms of length of hospital stay and a lower incidence of postoperative parenteral narcotic analgesic requirement although when post-operative parenteral narcotics were required by the LA group of patients, the difference in mean total pethidine requirement was not statistically significant.

Entities:  

Mesh:

Year:  1998        PMID: 9814745     DOI: 10.1111/j.1445-2197.1998.tb04680.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  2 in total

1.  Comparison of buffered and unbuffered local anaesthesia for inguinal hernia repair: a prospective study.

Authors:  E L Ball; P Sanjay; A Woodward
Journal:  Hernia       Date:  2006-01-20       Impact factor: 4.739

Review 2.  Should we abandon regional anesthesia in open inguinal hernia repair in adults?

Authors:  B Bakota; M Kopljar; S Baranovic; M Miletic; M Marinovic; D Vidovic
Journal:  Eur J Med Res       Date:  2015-09-17       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.